Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/3/2020
SIETES contiene 92954 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Kloprogge F, Workman L, Bormann S, Tékété M, Lefèvre G, Hamed K, Piola P, Ursing J, Kofoed PE, Martensson A, Ngasala B, Björkman A, Ashton M, Hietala SF, Aweeka F, Parikh S, Mwai L, Davis TME, Karunajeewa H, Salman S, Checchi F, Fogg C, Newton PN, Mayxay M, Deloron P, Faucher JF, Nosten F, Ashley EA, McGready R, van Vugt M, Proux S, Price RN, Karbwang J, Ezzet F, Bakshi R, Stepniewska K, White NJ, Guerin PJ, Bames KI, Tarning J. Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLOS Medicine 2018:12 de junio. [Ref.ID 102769]
2. Cita con resumen
Anónimo. Vaccin paludique RTS,S/AS01E. Prescrire 2016;36:725-6. [Ref.ID 100886]
3.Tiene citas relacionadas Cita con resumen
Friedrich MJ. Artemisinin-resistant malaria. JAMA 2012;307:2017. [Ref.ID 93065]
4.Tiene citas relacionadas Cita con resumen
Phyo A, Nikhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ier Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NPJ, White NJ, Anderson TJC, Nosten F. Emergence of artemisin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012;379:1960-6. [Ref.ID 93060]
5.Enlace a cita original
Jolink H, den Hartigh J, Visser LG, van Nieuwkoop C. Pancytopenia due to proguanil toxicity in a returning traveller with fever. Eur J Clin Pharmacol 2010;66:811-2. [Ref.ID 89062]
6.
Crawley J, Chu C, Mtove G, Nosten F. Malaria in children. Lancet 2010;375:1468-81. [Ref.ID 88420]
7.Enlace a cita original
Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ. Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria. PLOS Medicine 2008;5:227. [Ref.ID 84573]
8. Cita con resumen
Feachem R, Sabot O. A new global malaria eradication strategy. Lancet 2008;371:1633-5. [Ref.ID 82876]
9.Tiene citas relacionadas
Zuccotti G, DeAngelis CD. Malaria 2007 - progressing research, persisting challenges. JAMA 2007;297:2285-6. [Ref.ID 80177]
10.Tiene citas relacionadas
Feachem RGA, Sabot OJ. Global malaria control in the 21st century. A historic but fleeting opportunity. JAMA 2007;297:2281-4. [Ref.ID 80176]
11.Tiene citas relacionadas
Chretien JP, Fukuda M, Noedl H. Improving surveillance for antimalarial drug resistance. JAMA 2007;297:2278-81. [Ref.ID 80175]
12.Tiene citas relacionadas
Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States. A systematic review. JAMA 2007;297:2264-77. [Ref.ID 80174]
13.Tiene citas relacionadas
Chen LH, Wilson ME, Schlagenhauf P. Controversies and musconceptions in malaria chemoprohylaxis for travelers. JAMA 2007;297:2251-63. [Ref.ID 80173]
15.Tiene citas relacionadas
Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ. Combination therapy for uncomplicated falciparum malaria in Ugandan children. A randomized trial. JAMA 2007;297:2210-9. [Ref.ID 80171]
16.Tiene citas relacionadas
Leslie T, Mayan MI, Hasan MA, Safi MH, Klinkerberg E, Whitty CJM, Rowland M. Sulfadoxine-pyrimethamine, clorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan. A randomized controlled trial. JAMA 2007;297:2201-9. [Ref.ID 80170]
17.Tiene citas relacionadas
Croft AM, Darbyshire AH, Jackson CJ, van Thiel PP. Malaria prevention measures in coalition troops in Afghanistan. JAMA 2007;297:2197-8. [Ref.ID 80169]
18. Cita con resumen
Ratcliff A, Siswantoro H, Kenangalem E, Maristela R, Wuwung RM, Ebsworth EP, Anstey NM, Tjitra E, Price RN. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vival malaria in Papua, Indonesia: an open-label randomised comparison. Lancet 2007;369:757-65. [Ref.ID 79414]
19.
Maitland K, Nadel S, Pollard AJ, Williams TN, Newton CRJC, Levin M. Management of severe malaria in children: proposed guidelines for the United Kingdom. BMJ 2005;331:337-43. [Ref.ID 74574]
20.Tiene citas relacionadas Cita con resumen
Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, Mshinda H, Alonso P. Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised placebo-controlled trial. Lancet 2005;365:1481-3. [Ref.ID 73620]
Seleccionar todas
 
 1 a 20 de 32 siguiente >>